In 1927 Maximov described a population of "embryonale nichtspeichernde Reticulumzellen" ("embryonal non-phagocytic reticulum cells") which are present within the cortical follicles of peripheral lymphoid tissue.1 Since this original description these cells, usually referred to as "dendritic reticulum cells" (DRC), have been the subject of numerous electron microscopic and cytochemical studies.26 DRC are found in primary lymphoid follicles and in the germinal centres of secondary lymphoid follicles, where their long branching processes form a delicate three-dimensional network within which germinal centre lymphoid cells are enmeshed.2 3 I DRC have been shown by autoradiographic and immunohistological techniques to have a high affinity for immune complexes.7 They thus appear to play a primary role in the trapping of antigen within germinal centres. They may also be involved in B cell homing since neoplastic germinal centre cells in cases of follicular lymphoma can be shown by light and electron microscopy to accumulate within a meshwork of DRC.
Since DRC (and especially their long cytoplasmic processes) are difficult to recognise by conventional light microscopy attempts have been made to reveal them using enzyme histochemical techniques. 5'-Accepted for publication 2 August 1982 nucleotidase has proved the most suitable enzyme for this purpose, high levels of activity being detectable on the surface membrane of DRC.8 I However the value of this enzyme as a marker of DRC is limited by the fact that it is also present on the surface of follicular mantle cells and some germinal centre cells8 and also by the susceptibility of the 5'-nucleotidase histochemical reaction to technical artefacts (own unpublished observations). There is hence a need for a more specific technique which will allow DRC to be identified and thus enable abnormalities in their distribution in different disease states to be investigated.
In the present paper we describe the production of a monoclonal antibody which reacts strongly with human dendritic reticulum cells (and also weakly with a subset of B cells). This antibody has already proved of great value in analysing the distribution of DRC in reactive lymphoid tissue and in lymphomas of germinal centre origin. It should also prove of value in the future for the isolation of DRC in a high degree of purity from human lymphoid tissue. This antibody was produced during a fusion experiment aimed at raising monoclonal antibodies specific for human C3 receptors. BALB/c mice were immunised by a schedule previously used for raising polyclonal rabbit antiserum against human C3 receptors.'0 The antigen consisted of sheep red cells which had been incubated sequentially with rabbit antisheep cell antiserum, followed by C3-deficient rabbit serum. These EAC were then incubated in a complement receptor-rich KBr extract of normal human tonsil cell membranes in order to coat them with C3 receptor.
Material and methods

TISSUES
The mouse used for the fusion experiment which produced the anti-DRC antibody had received two intravenous injections of C3 receptor-coated red cells before receiving a final intravenous immunisation. Four days later 108 spleen cells were fused with 107 NS-1 myeloma cells using polyethylene glycol as fusing agent." The Cryostat sections (5-10pm) were picked up on gelatin coated slides and dried for 4-18 h in the vacuum chamber of a freeze drying apparatus. After fixation for 10 min in acetone at room temperature they were air dried and then either stained immediately by the immunoperoxidase procedure (see below) or wrapped in aluminium foil and stored at -200C. IMMUNOPEROXIDASE 
STAINING
Monoclonal antibodies (see above) were applied to dry cryostat sections. Culture supernatants containing monoclonal antibodies were used undiluted. Purified monoclonal antibodies or ascitic fluid samples containing monoclonal antibodies were tested over a range of dilutions on tissue sections and subsequently used at their optimal concentrations.
After 30 min incubation with antibody at room temperature in a covered chamber, sections were washed in TBS, and incubated for a further 30 min with peroxidase-conjugated antimouse Ig (1/5-1/50) diluted in TBS to which normal human serum had been added (at a final dilution of 1/3-1/25) in order to block reactivity against human Ig. Sections were then washed in TBS before incubation with diaminobenzidine (0.5 mg/ml) and H202 (0.01%) diluted in TBS.'5 The peroxidase reaction was terminated by washing in buffer or tap water after 5-10 min and sections were counterstained with haematoxylin before mounting for microscopic examination. 
Results
CHARACTERISTICS OF ANTIBODY R4/23
The monoclonal antibody R4/23 was shown by Ouchterlony immunodiffusion to be an IgM kappa antibody. The cell line producing the antibody has proved stable during several weeks of in vitro culture and can consistently be recovered from the frozen state. In pristane-primed BALB/c mice the cell line produces an ascitic tumour secreting antibody R4/23. (Fig. 1) . In the germinal centres of secondary follicles the network revealed by R4/23 was present throughout the entire structure, including the centroblast-rich zone, although this region was often less strongly stained than the centrocyte-rich area. At a higher magnification it was evident that the dendritic staining pattern seen in secondary follicles penetrated beyond the germinal centres into the mantle zone of small lymphocytes (Fig. 2) .
This staining pattern strongly suggested that antibody R4/23 reacts with DRC. This interpretation was supported by comparing the reactions of lymphoid follicles stained with R4/23 with those obtained using antibodies specific for IgM, IgG, IgA and C3b (all of which are present within the immune complexes bound to DRC'6) and also for C3 receptors (present on DRCI').
It was evident from this comparison that there was a close parallelism between the reaction for these three markers. This was particularly obvious when abnormal follicles were examined in which the diffuse network of DRC revealed by R4/23 contained negative lacunae (Fig. 3) .
In addition to the strong staining of presumptive DRC, antibody R4/23 gave weak surface staining of small lymphoid cells at the periphery of mantle zones in lymph node cortical follicles. Staining of splenic tissue sections with antibody R4/23 showed intense staining in a DRC-like pattern of B cell follicles. Lymphoid cells present within these follicles were 150 cases of non-Hodgkin's lymphoma (NHL), 50 completely unstained, but there was distinct, though cases of Hodgkin's disease, five cases of malignant weak, surface staining of the small lymphoid cells histiocytosis and four cases of histiocytosis X. The resurrounding B cell follicles ("marginal zone sults indicated that the reactivity of R4/23 was comcells" -Fig. 4 cases of follicular lymphoma consisted of a lymph node. The exception was a case of follicular lymphoma involving the kidney. In this biopsy the neoplastic cells showed a tendency to form nodular structures (most readily recognised when stained with monoclonal anti-B cell antibody- Fig. 6 ). Staining with R4/23 revealed that many of these nodules contained a network of DRC (Fig. 6 ). These DRC clusters could also be delineated by labelling with anti-C3b receptor (Fig. 6) .
In cases of germinal centre cell-derived lymphomas of the centrocytic type showing a diffuse growth pattern, it was also possible to stain many DRC with antibody R4/23. The DRC in these cases formed a network, although this was not as sharply defined as in follicular centroblastic-centrocytic lymphoma (Fig. 7) . When germinal centre cellderived lymphomas of centroblastic type were studied only two of six cases contained a network of DRC.
B cell lymphomas ofnon-germinal centre cell origin
In these cases staining with R4/23 revealed very few or no detectable DRC. In those cases in which surviving areas of DRC staining could be identified, labelling for C3b receptor gave the same staining pattern as that observed with R4/23 (Fig. 8) .
HODGKIN S DISEASE
Two patterns of DRC distribution were observed when studying Hodgkin's disease. The commonest pattern, seen in all types of Hodgkin's disease with the exception of lymphocyte predominant Hodgkin's disease, was that DRC clusters were partially or totally obliterated by the disease process. However in four cases of lymphocyte predominant Hodgkin's disease there was marked expansion of B cell areas as recognised by staining for DRC and for B cell markers.
All samples of Hodgkin's disease were carefully analysed to see whether antibody R4/23 reacted with Reed-Sternberg or Hodgkin's cells, but in no instances was such staining observed.
Discussion
The data presented in this paper indicate that antibody R4/23 detects an antigen ( (Fig. 8) . In contrast, all types of germinal centre cell-derived lymphomas (centroblastic-centrocytic, centrocytic and at least a few centroblastic) showed a more or less dense network of DRC with accumulations of neoplastic B cells between and around them. This was especially true in follicular centroblastic-centrocytic lymphoma, which constantly exhibited a nodular network of DRC (Fig.  5) . Such an intimate association between DRC and neoplastic B cells appears to be pathognomonic for lymphomas derived from germinal centre cells.
The staining pattern obtained with R4/23 in the case of follicular non-Hodgkin's lymphoma infiltrating the kidney was of particular interest. The areas of lymphomatous infiltration were associated with clusters of DRC (Fig. 6) . Since 
